Study of stenting plus medical management compared to medical management alone in preventing recurrence of ischemic stroke

The objective of the study is to determine whether intensive medical therapy plus intracranial angioplasty and stenting is superior to intensive medical therapy alone for preventing recurrence of ischemic stroke.

Nationwide, 764 patients will be recruited for this study.  At Rush University Medical Center we expect to recruit approximately 20 patients. The treatment will be assigned randomly.

You may be eligible to participate in this study if you:

• Are ≥ 30 years of age and ≤ 80 years of age
• Have had a TIA or non-severe stroke within 30 days of enrollment attributed to severe intracranial stenosis (narrowing of the artery due to plaque buildup)

You will be excluded from this study if you:

• Suffered a severe (disabling) stroke
• Had a stroke that was caused by a hemorrhage or thrombus (clot)
• Have received previous treatment of target lesion with a stent, angioplasty, or other mechanical device

This is a partial list of eligibility requirements. To inquire about your eligibility, please call the contact number provided. If you wish to inquire via e-mail, please include the title of the study in your message.